Stock listing

NASDAQ:CDT CDT Equity Inc. Stock

Home listing (NASDAQ) of CDT Equity Inc.

Follow CDT Equity Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CDT

$0.23 USD -0.04 (-13.9%)

Close on Nov 20, 2026

Past year -100.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.223 – $0.245 USDNov 20, 2026
Volume
853,743 sharesNov 20, 2026
Market cap
$234,109 USDAt the close on Nov 20, 2026 · price × 1.02M shares outstanding
52-week range
$0.065 – $14,562.50 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$835,037 USDMedian day 23,705 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
CDT Equity Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CDT · Home$0.23 USD-0.037 (-13.9%)853,743$0.234$0.245$0.223$0.267Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CDT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.23-0.037-13.9%$0.234$0.245$0.223853,743
$0.267-0.076-22.1%$0.287$0.30$0.2612,466,465
$0.343-0.017-4.7%$0.355$0.36$0.322224,469
$0.36-0.017-4.5%$0.375$0.38$0.342337,079
$0.377-0.023-5.8%$0.416$0.417$0.351299,190
$0.40-0.043-9.7%$0.435$0.448$0.38776,800
$0.443-0.067-13.1%$0.495$0.503$0.44518,700
$0.51-0.051-9.1%$0.483$0.56$0.4541,429,900
$0.561-0.279-33.2%$0.77$0.77$0.561944,400
$0.84-0.47-35.9%$1.08$1.08$0.8213,389,100
$1.31+0.47+56.0%$1.38$1.61$0.98127,133,000
$0.84-0.18-17.6%$0.94$0.94$0.784,864,260
$1.02-0.32-23.9%$1.00$1.02$0.94319,540
$1.34-0.06-4.3%$1.32$1.40$1.20215,210
$1.40+1.332+1958.8%$1.24$1.42$1.085,304,075
$0.068-0.009-11.7%$0.068$0.07$0.065269,745
$0.077-0.006-7.2%$0.077$0.077$0.069360,300
$0.083+0.003+3.8%$0.09$0.092$0.0667,765,980
$0.08-0.014-14.9%$0.089$0.092$0.076264,860
$0.094-0.036-27.7%$0.119$0.119$0.09347,870
$0.130.000.0%$0.132$0.174$0.125298,835
$0.13-0.015-10.3%$0.141$0.144$0.128109,175
$0.145-0.014-8.8%$0.16$0.161$0.13886,075
$0.159-0.027-14.5%$0.174$0.178$0.14595,810
$0.186-0.049-20.9%$0.199$0.209$0.17267,715
$0.235+0.026+12.4%$0.20$0.242$0.192593,400
$0.209-0.031-12.9%$0.197$0.217$0.181110,435
$0.24-0.21-46.7%$0.243$0.252$0.1951,117,330
$0.45-0.21-31.8%$0.591$0.611$0.41548,320
$0.66-0.058-8.1%$0.702$0.713$0.63118,250
$0.718-0.082-10.3%$0.79$0.797$0.7023,320
$0.80-0.036-4.3%$0.821$0.851$0.79613,155
$0.836-0.094-10.1%$0.899$0.899$0.80424,090
$0.93+0.012+1.3%$0.90$0.94$0.85145,915
$0.918-0.072-7.3%$0.973$0.973$0.8517,640
$0.99-0.26-20.8%$1.28$1.28$0.9551,270
$1.25-0.11-8.1%$1.34$1.371$1.2212,955
$1.36-0.09-6.2%$1.45$1.556$1.3416,360
$1.45-0.45-23.7%$1.87$1.884$1.4429,990
$1.90-0.10-5.0%$1.875$1.925$1.702,439
$2.00-1.025-33.9%$2.20$2.225$1.9752,133
$3.025-0.35-10.4%$3.025$3.175$3.00592
$3.375-0.175-4.9%$3.45$3.60$3.275932
$3.55-0.30-7.8%$3.75$3.75$3.251,001
$3.85-0.50-11.5%$4.15$4.25$3.825358
$4.35-0.40-8.4%$4.025$4.425$3.9251,446
$4.75-0.20-4.0%$5.15$5.15$4.50322
$4.95-0.125-2.5%$5.175$5.20$4.625381
$5.075-0.40-7.3%$5.30$5.425$4.825460
$5.475-0.775-12.4%$5.50$5.675$5.225434
$6.25-2.375-27.5%$6.425$6.45$5.75816
$8.625-6.375-42.5%$10.30$10.30$8.1253,572
$15.00-0.425-2.8%$15.00$15.50$14.5010
$15.42-0.20-1.3%$15.00$16.60$14.5526
$15.63-3.10-16.6%$18.25$18.63$15.3059
$18.72-4.025-17.7%$22.00$22.15$17.5061
$22.75-14.25-38.5%$28.75$30.00$22.50104
$37.00-5.00-11.9%$42.50$42.75$35.00219
$42.00-0.25-0.6%$42.75$44.75$40.0011
$42.25-4.75-10.1%$49.50$50.75$40.5039
$47.00-0.25-0.5%$47.25$49.25$45.0012
$47.25-4.00-7.8%$52.75$52.75$45.507
$51.25-11.00-17.7%$60.25$61.25$48.0040
$62.25-9.25-12.9%$73.75$74.50$61.505
$71.50-1.00-1.4%$74.75$85.00$71.006
$72.50-2.75-3.7%$74.00$75.25$70.502

Splits

6 splits since 2025 · NASDAQ:CDT · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
1-for-10Consolidation
1-for-25Consolidation
1-for-8Consolidation
1-for-15Consolidation
1-for-100Consolidation
Ticker
NASDAQ:CDT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All CDT Equity Inc. news

CDT Equity Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
28 in the last 12 months · 66 in all · newest Nov 19, 2026 · oldest 2022
Decks
2 decks · latest Jul 21, 2023

Where CDT Equity Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CDT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CDTBOATSUnited StatesUSD
Frankfurt:ZK7FrankfurtGermanyEUR

Valuation

Price/book 0.0× against a median of 0.2×: the lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$1.49M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.0×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.14

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
Jaguar Health, Inc. · NASDAQ:JAGXUS$527,406−US$1.48Mn/a−0.1×n/a0.0×−181.8%0.2×3.75
Altamira Therapeutics Ltd. · OTC:CYTOFUS$404,655US$400,900n/an/an/a0.1×n/a0.0×0.64
NKGen Biotech Inc. · OTC:NKGNUS$391,807US$38.58Mn/an/an/an/an/an/a0.88
Vaxil Bio Ltd. · TSXV:VXLUS$319,500−US$4,0701.2×n/an/a0.4×n/a0.0×-0.16
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
Median of the othersUS$278,926US$73,5101.2×0.3×0.2×−262.8%0.1×1.20

Team and board

Officers

OfficerRole
James BlighChief Executive Officer

Board

DirectorRole
Ulrik OlsenBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026−10.0%
Q2 2026Aug 12, 2026+6.3%
Q1 2026Jun 25, 2026−41.6%
Q3 2025Nov 12, 2025 · After close−7.2%
Q2 2025Aug 14, 2025 · After close0.0%
Q1 2025May 15, 20250.0%
Q4 2024Mar 28, 20250.0%
Q4 2022Mar 28, 20230.0%
Q3 2022Nov 7, 20220.0%
Q2 2022Aug 11, 20220.0%
All 11 quarters
QuarterResultsShare move
Q1 2022May 18, 20220.0%

Open Events

Decks

DeckKindSlidesDate
Murphy Canyon Acquisition — SPAC Merger (July 2023)SPAC merger30 slidesJul 21, 2023
Conduit Pharmaceuticals — SPAC Merger (November 2022)SPAC merger29 slidesNov 8, 2022

Open Decks

IPO

Withdrawn on Jan 26, 2022. Filed with the SEC to go public on Jan 6, 2022, as Murphy Canyon Acquisition Corp., a blank check company (SPAC).

Price
US$10.00 a unit
Units offered
11,500,000 units
Offering size
US$115 million
Underwriters' option
Up to 1,725,000 more units
Listing
MURFU on the Nasdaq Global Market
Underwriters
A.G.P., The Benchmark Company, LLC · In the order on the cover
Units delivered
On or about Feb 7, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceDec 9, 2021
Filed publiclyJan 6, 2022
Amended onceJan 28, 2022
Filing withdrawnJan 26, 2022

Open IPO · From the cover of the final prospectus (424B5) filed Feb 4, 2022

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue2.72B922.2M000
Cost of revenue1.68B457.0K
Gross profit1.03B-457.0K
Research and development5.05M3.38M90.0K37.0K283.0K
Selling, general and administrative31.7M12.0M5.17M3.05M2.89M
Operating income-36.8M-15.4M-5.26M-3.16M-3.17M
Depreciation and amortization2.42M10.0K01.73M484.0K
EBITDA-34.3M-15.4M-5.26M-1.43M-2.69M
Interest expense200.0K32.0K0100.0K
Income before tax-39.2M-17.8M-536.0K773.5K-3.66M
Income tax29.3M-29.5M-168.0K374.9K247.4K
Net income-39.2M-17.8M-535.0K-4.89M-3.66M
Earnings per share, basic-1,177.89-61,598.62-0.79-0.13
Earnings per share, diluted-1,177.89-61,598.62-8.92-0.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents1.51M554.0K4.23M345.8K48.6K
Short-term investments600.0K4.20M
Receivables462.8M489.0K
Inventory402.3M343.1M
Current assets4.38M2.71M5.73M646.6K104.2K
Property, plant and equipment269.0K40.0K
Goodwill1.04B1.02B
Total assets5.65M4.19M7.22M5.00K213.1K
Accounts payable1.91M1.43M215.0K0
Current liabilities12.8M10.7M1.80M4.18M192.5K
Long-term debt2.01M749.0K
Total debt1.29B7.46M985.0K2.01M177.1K
Total liabilities12.8M11.0M7.68M10.1M192.5K
Shareholders' equity-7.17M-6.79M-457.0K-10.1M20.6K
Shares outstanding18461738.3K64.6M240

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-15.6M-9.68M-7.72M-2.27M-2.15M
Capital spending-2.40M-51.0K00-5
Free cash flow-18.0M-9.73M-7.72M-2.27M-2.15M
Cash from investing-808.0K-43.0K725.0K-183.0K48.6K
Cash from financing17.4M6.07M10.9M2.45M1.90M
Dividends paid-7.97M-8.20M
Share buybacks-106.0K0
Change in cash955.0K-3.67M4.23M297.2K-252.0K

Open Financials

Filings

FilingDateTypeFiled with
424B3 · ProspectusNov 17, 2026Offer documentSEC
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
424B3 · ProspectusNov 16, 2026Offer documentSEC
8-K · Current reportNov 16, 2026Meeting outcomeSEC
424B3 · ProspectusNov 9, 2026Offer documentSEC
8-K · Current reportNov 9, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
424B3 · ProspectusNov 4, 2026Offer documentSEC
8-K · Current reportNov 4, 2026Current reportSEC
424B3 · ProspectusNov 3, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
DEF 14A · Proxy statementOct 27, 2026Meeting noticeSEC
4 · Change in ownershipOct 27, 2026Insider tradeSEC
4/A · Change in ownership, amendedOct 27, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
3 · Initial statement of ownershipOct 27, 2026Insider tradeSEC
8-K · Current reportOct 27, 2026Material contractSEC
PRE 14A · Preliminary proxy statementOct 16, 2026Meeting noticeSEC
424B3 · ProspectusOct 13, 2026Offer documentSEC
8-K · Current reportOct 13, 2026Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 8, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeOct 7, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 7, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 7, 2026Big-stake noticeSEC
424B3 · ProspectusOct 2, 2026Offer documentSEC
8-K · Current reportSep 25, 2026Current reportSEC
424B3 · ProspectusSep 18, 2026Offer documentSEC
8-K · Current reportSep 18, 2026Material contractSEC
424B3 · ProspectusSep 18, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 18, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeSep 9, 2026Big-stake noticeSEC
S-1 · Registration statementSep 8, 2026Offer documentSEC
8-K · Current reportSep 4, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeSep 2, 2026Big-stake noticeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 2, 2026Big-stake noticeSEC
8-K · Current reportSep 1, 2026Current reportSEC
8-K · Current reportSep 1, 2026Management or board changeSEC
SCHEDULE 13G · Big-stake noticeAug 21, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 21, 2026Big-stake noticeSEC
8-K/A · Current report, amendedAug 21, 2026Current reportSEC
8-K/A · Current report, amendedAug 21, 2026Acquisition or disposalSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialAug 12, 2026Meeting noticeSEC
ARS · Annual report to shareholdersAug 11, 2026Annual reportSEC
DEF 14A · Proxy statementAug 11, 2026Meeting noticeSEC
8-K · Current reportAug 6, 2026Material contractSEC
8-K/A · Current report, amendedAug 3, 2026Acquisition or disposalSEC
PRE 14A · Preliminary proxy statementJul 31, 2026Meeting noticeSEC
8-K · Current reportJul 31, 2026Material contractSEC
8-K · Current reportJul 29, 2026FinancingSEC
8-K · Current reportJul 16, 2026Current reportSEC
10-Q · Quarterly reportJul 15, 2026Quarterly reportSEC
8-K · Current reportJul 7, 2026Material contractSEC
8-K · Current reportJun 29, 2026Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 23, 2026Big-stake noticeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
8-K · Current reportJun 16, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeJun 5, 2026Big-stake noticeSEC
8-K · Current reportMay 28, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeMay 20, 2026Big-stake noticeSEC
NT 10-Q · Late filing noticeMay 15, 2026Explanation requestSEC
8-K · Current reportMay 15, 2026Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 14, 2026Big-stake noticeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 4, 2026Other filingsSEC
424B3 · ProspectusMay 1, 2026Offer documentSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
CORRESP · Letter to the SECApr 30, 2026Other filingsSEC
UPLOAD · Letter from the SECApr 29, 2026Other filingsSEC
8-K · Current reportApr 27, 2026Management or board changeSEC
S-3 · Registration statementApr 21, 2026Offer documentSEC
10-K · Annual reportApr 15, 2026Annual reportSEC
424B5 · ProspectusApr 2, 2026Offer documentSEC
NT 10-K · Late filing noticeApr 1, 2026Explanation requestSEC
4 · Change in ownershipMar 30, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 30, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMar 30, 2026Big-stake noticeSEC
8-K · Current reportMar 25, 2026Current reportSEC
8-K · Current reportMar 18, 2026Meeting outcomeSEC
8-K · Current reportMar 9, 2026Material contractSEC
DEF 14A · Proxy statementMar 6, 2026Meeting noticeSEC
8-K · Current reportFeb 24, 2026Material contractSEC
PRE 14A · Preliminary proxy statementFeb 24, 2026Meeting noticeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 18, 2026Big-stake noticeSEC
424B3 · ProspectusFeb 10, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 10, 2026Other filingsSEC
CORRESP · Letter to the SECFeb 6, 2026Other filingsSEC
UPLOAD · Letter from the SECFeb 6, 2026Other filingsSEC
S-8 · Registration statement for employee plansJan 30, 2026Offer documentSEC
S-3 · Registration statementJan 29, 2026Offer documentSEC
8-K · Current reportJan 22, 2026Material contractSEC
8-K · Current reportJan 2, 2026Material contractSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedDec 22, 2025Big-stake noticeSEC
S-8 POSDec 12, 2025Offer documentSEC
8-K · Current reportDec 12, 2025Material contractSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportOct 9, 2025Current reportSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 22, 2025Big-stake noticeSEC
4 · Change in ownershipSep 22, 2025Insider tradeSEC
4 · Change in ownershipSep 19, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 18, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
10-Q/A · Quarterly report, amendedAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025Current reportSEC
424B3 · ProspectusAug 12, 2025Offer documentSEC
S-8 · Registration statement for employee plansAug 11, 2025Offer documentSEC
8-K · Current reportAug 8, 2025Management or board changeSEC
EFFECT · Notice that a registration is effectiveAug 8, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 5, 2025Other filingsSEC
CORRESP · Letter to the SECAug 5, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 31, 2025Big-stake noticeSEC
S-3 · Registration statementJul 31, 2025Offer documentSEC
DEF 14A · Proxy statementJul 9, 2025Meeting noticeSEC
ARS · Annual report to shareholdersJul 8, 2025Annual reportSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
8-K · Current reportJun 9, 2025Material contractSEC
8-K · Current reportJun 3, 2025Current reportSEC
8-K · Current reportMay 16, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
SCHEDULE 13G · Big-stake noticeMay 7, 2025Big-stake noticeSEC
3 · Initial statement of ownershipMay 7, 2025Insider tradeSEC
8-K · Current reportMay 6, 2025Meeting outcomeSEC
EFFECT · Notice that a registration is effectiveMay 1, 2025Other filingsSEC
CORRESP · Letter to the SECApr 28, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 28, 2025Other filingsSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
8-K · Current reportApr 25, 2025Current reportSEC
S-3 · Registration statementApr 22, 2025Offer documentSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementApr 16, 2025Meeting noticeSEC
8-K · Current reportApr 16, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 10, 2025Big-stake noticeSEC
8-K · Current reportApr 4, 2025Material contractSEC
8-K/A · Current report, amendedApr 2, 2025Current reportSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
4 · Change in ownershipApr 1, 2025Insider tradeSEC
8-K · Current reportApr 1, 2025Current reportSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
424B5 · ProspectusMar 10, 2025Offer documentSEC
8-K · Current reportMar 6, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 20, 2025Big-stake noticeSEC
8-K · Current reportFeb 19, 2025Current reportSEC
424B5 · ProspectusFeb 19, 2025Offer documentSEC
424B3 · ProspectusFeb 14, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 13, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 11, 2025Other filingsSEC
UPLOAD · Letter from the SECFeb 11, 2025Other filingsSEC
8-K · Current reportFeb 11, 2025Current reportSEC
424B5 · ProspectusFeb 10, 2025Offer documentSEC
S-8 · Registration statement for employee plansFeb 6, 2025Offer documentSEC
424B5 · ProspectusFeb 6, 2025Offer documentSEC
S-3 · Registration statementFeb 5, 2025Offer documentSEC
8-K · Current reportJan 23, 2025Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 21, 2025Big-stake noticeSEC
424B5 · ProspectusJan 15, 2025Offer documentSEC
8-K · Current reportJan 14, 2025Meeting outcomeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
4 · Change in ownershipDec 20, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 20, 2024Insider tradeSEC
8-K · Current reportDec 20, 2024Meeting outcomeSEC
8-K · Current reportDec 17, 2024Material contractSEC
424B3 · ProspectusDec 16, 2024Offer documentSEC
DEF 14A · Proxy statementDec 9, 2024Meeting noticeSEC
424B3 · ProspectusDec 9, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 9, 2024Other filingsSEC
CORRESP · Letter to the SECDec 4, 2024Other filingsSEC
UPLOAD · Letter from the SECDec 2, 2024Other filingsSEC
PRE 14A · Preliminary proxy statementNov 26, 2024Meeting noticeSEC
S-3 · Registration statementNov 25, 2024Offer documentSEC
8-K · Current reportNov 25, 2024Material contractSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
4 · Change in ownershipNov 20, 2024Insider tradeSEC
8-K · Current reportNov 19, 2024Management or board changeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
10-Q/A · Quarterly report, amendedNov 14, 2024Quarterly reportSEC
10-Q/A · Quarterly report, amendedNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 6, 2024Big-stake noticeSEC
424B5 · ProspectusNov 4, 2024Offer documentSEC
424B3 · ProspectusNov 4, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 4, 2024Other filingsSEC
DEFA14A · Additional proxy materialNov 1, 2024Meeting noticeSEC
8-K · Current reportNov 1, 2024Material contractSEC
CORRESP · Letter to the SECOct 31, 2024Other filingsSEC
UPLOAD · Letter from the SECOct 29, 2024Other filingsSEC
ARS · Annual report to shareholdersOct 28, 2024Annual reportSEC

This page holds 200 of 375 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from CDT Equity Inc.’s releases

Common shares
1,017,864
Fully diluted
1,017,864

Fully diluted

LineShares
Common shares1,017,864

Share count over time

CountShares
Nov 22, 20261,017,864

Open Cap table

Shareholders

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund3,8560.20%US$4,010May 31, 2026
Fidelity Nasdaq Composite Index Fund1,9710.10%US$2,050May 31, 2026
Fidelity Series Total Market Index Fund50<0.01%US$52May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Regan Andrew
Director, Officer: Chief Executive Officer, 10% owner
Sale29Aug 28, 2026
Regan Andrew
Director, Officer: Chief Executive Officer
Sale290Aug 28, 2026
Prospect Capital Securities Ltd
10% owner
Sale5,000USD 0.71US$3,550Jun 18, 2026
Prospect Capital Securities Ltd
10% owner
Sale1,464,711USD 1.44US$2.11MJun 18, 2026
Prospect Capital Securities Ltd
10% owner
Sale5,000USD 0.75US$3,750Jun 18, 2026
Prospect Capital Securities Ltd
10% owner
Sale593,289USD 1.40US$831KJun 18, 2026

Big stakes

StakeStakeSharesDateFiling
Andrew Regan5.40%263KMar 24, 2026Schedule 13D
Nirland Limited1.60%75,315Feb 19, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Knuettel Francis II
Other companies: OS Therapies Incorporated (Chief Financial Officer · Since at least Nov 10, 2026); Splash Beverage Group, Inc. (nv) (Director · Since at least Apr 27, 2026); Beeline Holdings, Inc. (Director · Since at least May 14, 2025); Pelthos Therapeutics Inc. (CFO, Treas & Secty · Since at least Feb 15, 2024); Tevogen Bio Holdings Inc. (Chief Financial Officer · Jun 7, 2023 – Jun 7, 2023 · Past); Oceantech Acquisitions I Corp (Chief Financial Officer · Mar 13, 2023 – Mar 13, 2023 · Past); Forum Markets, Incorporated (Director · Jul 2, 2021 – Sep 4, 2023 · Past); Unrivaled Brands Inc (CEO and President, Director · Jun 7, 2021 – Jun 18, 2021 · Past); SCWorx Corp. (Director · Feb 1, 2019 – Nov 26, 2019 · Past); Aqua Metals, Inc. (Chief Financial Officer · May 9, 2018 – Jun 15, 2018 · Past); Spindle Inc (Director · Oct 21, 2015 – Jun 30, 2017 · Past); MARA Holdings, Inc. (CHIEF FINANCIAL OFFICER · May 15, 2014 – Nov 3, 2014 · Past)
Director · Feb 2, 2022 – Feb 2, 2022 · Past
Freda Lewis-Hall
Other companies: Pyxis Oncology, Inc. (Director · Since at least Oct 7, 2021); SpringWorks Therapeutics Inc (Director · Since at least Mar 29, 2019); EXACT Sciences Corporation (Director · Apr 22, 2020 – Jun 8, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Pfizer, Inc. (Executive Vice President · Feb 22, 2018 – Feb 27, 2019 · Past)
Director · Since at least Sep 22, 2023
Chele Chiavacci Farley
Other companies: General Purpose Acquisition Corp. (Director · Since at least Dec 2, 2025)
Director · Since at least Feb 2, 2022
Jack Kendrick Heilbron
Other companies: Presidio Property Trust, Inc. (Chief Executive Officer, Director · Since at least Feb 27, 2008)
CEO, President, and Chairman, Director · Feb 2, 2022 – Feb 2, 2022 · Past
Andrew ReganChief Executive Officer, Director · Since at least Sep 22, 2023
David TapolczayChief Executive Officer, Director · Sep 22, 2023 – Nov 18, 2024 · Past
James BlighChief Executive Officer · Since at least Sep 1, 2026
Simon FryDirector · Since at least Nov 19, 2024
Ulrik OlsenBoard Member · Since at least Apr 27, 2026

Open People

Log in to ask 6ix AI your own questions about CDT Equity Inc.